Chapter 22 Lipids and atherosclerosis

New Comprehensive Biochemistry

Volumn 36, Issue , 2002, Pages 573-597

  Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35448985051     PISSN: 01677306     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0167-7306(02)36024-1     Document Type: Article

References (30)

1. H.C. Stary Natural history and histological classification of atherosclerotic lesions: an update Arterioscler. Thromb. Vase. Biol. 20 2000 1177 1178
2. R. Ross Cell biology of atherosclerosis Annu. Rev. Physiol. 57 1995 791 804
3. C.K. Glass J.L. Witztum Atherosclerosis. The road ahead Cell 104 2001 503 516
4. K.J. Williams I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551 561
5. D.M. Small Progression and regression of atherosclerotic lesions Arteriosclerosis 8 1988 103 129
6. A.C. Newby P. Libby A.C. van der Wal Plaque instability - the real challenge for atherosclerosis research in the next decade? Cardiovasc. Res. 41 1999 321 322
7. K.J. Williams I. Tabas The response-to-retention hypothesis of atherogenesis, reinforced Curr. Opin. Lipidol. 9 1998 471 474
8. I. Tabas Nonoxidative modifications of lipoproteins in atherogenesis Annu. Rev. Nutr. 19 1999 123 139
9. I. Tabas Cholesterol and phospholipid metabolism in macrophages Biochim. Biophys. Acta 1529 2000 164 174
10. G.M. Chisolm D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28 2000 1815 1826
11. M. Navab J.A. Berliner A.D. Watson S.Y. Hama M.C. Territo A.J. Lusis D.M. Shih B.J. Van Lenten J.S. Frank L.L. Demer P.A. Edwards A.M. Fogelman The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture Arterioscler. Thromb. Vase. Biol. 16 1996 831 842
12. K. Oorni M.O. Pentikainen M. Ala-Korpela P.T. Kobanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res. 41 2000 1703 1714
13. I. Tabas Secretory sphingomyelinase Chem. Phys. Lipids 102 1999 131 139
14. M.S. Brown J.L. Goldstein Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis Annu. Rev. Biochem. 52 1983 223 261
15. T.Y. Chang C.C.Y. Chang D. Cheng Acyl-coenzyme A: cholesterol acyltransferase Annu. Rev. Biochem. 66 1997 613 638
16. S.S. Katz G.G. Shipley D.M. Small Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques J. Clin. Invest. 58 1976 200 211
17. I. Tabas Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions Trends Cardiovasc. Med. 7 1997 256 263
18. I. Tabas M. Krieger Lipoprotein receptors and cellular cholesterol metabolism in health and disease K. Chien Molecular Basis of Heart Disease 1999 W.B. Sanders New York 428 457
19. A.J. Brown W. Jessup Oxysterols and atherosclerosis Atherosclerosis 142 1999 1 28
20. D.J. Peet B.A. Janowski D.J. Mangelsdorf The LXRs: a new class of oxysterol receptors Curr. Opin. Genet. Dev. 8 1998 571 575
21. A.R. Tall P. Costet Y. Luo ‘Orphans’ meet cholesterol Nat. Med. 6 2000 1104 1105
22. P.N. Durrington Triglycerides are more important in atherosclerosis than epidemiology has suggested Atherosclerosis 141 Suppl 1 1998 S57 S62
23. G.A. FitzGerald S. Austin K. Egan Y. Cheng D. Pratico Cyclo-oxygenase products and atherothrombosis Ann. Med. 32 Suppl. 1 2000 21 26
24. C. Patrono G.A. FitzGerald Isoprostanes: potential markers of oxidant stress in atherothrombosic disease Arterioscler. Thromb. Vase. Biol. 17 1997 2309 2315
25. A. Sellmayer N. Hrboticky P.C. Weber Lipids in vascular function Lipids 34 1999 S13 S18 (Suppl.)
26. T.A. Sanders Polyunsaturated fatty acids and coronary heart disease Baillieres Clin. Endocrinol. Metab. 4 1990 877 894
27. J.L. Witztum J.A. Berliner Oxidized phospholipids and isoprostanes in atherosclerosis Curr. Opin. Lipidol. 9 1998 441 448
28. M. Navab J.A. Berliner G. Subbanagounder S. Hama A.J. Lusis L.W. Castellani S. Reddy D. Shih W. Shi A.D. Watson B.J. Van Lenten D. Vora A.M. Fogelman HDL and the inflammatory response induced by LDL-derived oxidized phospholipids Arterioscler. Thromb. Vase. Biol. 21 2001 481 488
29. E. Hurt-Camejo G. Camejo Potential involvement of type II phospholipase A2 in atherosclerosis Atherosclerosis 132 1997 1 8
30. S. Chatterjee Sphingolipids in atherosclerosis and vascular biology Arterioscler. Thromb. Vasc. Biol. 18 1998 1523 1533